… Given these discrepancies, our primary goal in this review and … on ketamine on synaptic
proteins [98], the evidence of ketamine … and new drug candidates-Nrf2 activators and GSK-3 …

… spine remodeling in regulating depressive behavior, the impact of early life … Targeting
synaptic structural plasticity within the NAc could … Ketamine, a pharmacological agent acting as a …

… a model of acute and subchronic ketamine treatment in rats [215], … Moreover, GSK-3 activation
appears to be also regulated by … -2/AKT1/GSK-3 pathway may represent a major target for …

… after psychedelics interventions and aim to provide a … The other five studies explored
the effects of ketamine in … 60 (P60) showed improved performance in the forced swim test …

… Of note, Ser9-inhibition is on a pool of free GSK-3 that is not … neurotransmission by
downregulating NMDA receptors. Lithium … The aim of the thesis was to investigate the possible …

… These predictors could be new biomarkers or targets for … The potential for anesthetics to
enhance cognitive performance … of the glutamate NMDA receptors by ketamine or esketamine …

… In this narrative literature review, we aim to address the absence of … action of PP results in
AMPA downregulation and LTD. … ketamine (0.5mg/kg), a psychotropic agent with established …

… have been used to target the precise regulator of apoptosis in … intracellular calcium entry
via NMDA receptors. Statins also … The GSK-3 is a conserved signaling molecule with essential …

… Interestingly, ketamine and its rapid and relatively sustained … Mice with targeted disruption
of genes involved in control of mutation rate, regulation of chromosome and telomere stability, …

… nucleus and their involvement in hormonal regulation (Klein et al. … Dopamine afferents
target two distinct populations of … also correlate with cognitive performance in human subjects, …